locums nephrology job in north island, new zealand
gmedical.com/job/job-3166...
08.03.2026 23:16
👍 12
🔁 3
💬 1
📌 0
locums nephrology job in north island, new zealand
gmedical.com/job/job-3166...
@dialysisbloke.bsky.social
Applied the VIPAR protocol to a patient with cAMR, first time in our centre.
Fingers crossed for positive results 🤞🏻
Just wanted to let you know that it’s being used out there 🤓
Nice. I will let Bill Mulley know. Hopefully goes well for your patient
✅ New Clinical Guidance for Kidney Stone Management
Managing kidney stones effectively requires timely decisions and tailored evaluation. This visual summary highlights key steps from acute presentation to post-stone evaluation:
I could return to where I had my first job out of medical school….there was no nephrologist there then. I worked for the Gen Physican who looked after the dialysis patients as my first rotation after med school. Must have made an impression
Delighted to see my Commentary published in the latest issue of #Circulation Journal
Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk–Reducing Intervention in Kidney Failure
Disagree? Happy to be challenged 💪🏼
#StopCardiacTests
Link to issue:
www.ahajournals.org/toc/circ/cur...
Registration now open
url.au.m.mimecastprotect.com/s/ZR0QCNLwzj...
* Causal Inference with Hidden Confounding
* Implementing the Estimand Framework in Clinical Trials
* Pairwise and Network Meta-analysis: Fundamentals and Beyond
* Cluster Randomised Trials: From Fundamentals to State-of-the-Art
Stop complaining about pill burden in ESRD!
There is no pill you are giving your dialysis patient that has data half as impressive as this study. If they are taking too many pills have them stop any of the dozen pills they are taking with ZEERO data in ESRD. #NephJC
Correct. Recruitment was super easy. Patients really liked the idea of a natural product.
A bit late to the party… apologies.
Maybe the most shocking study from #KidneyWk.
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
The International Vasculitis Workshop is pleased to announce the full speaker lineup for the 2026 event in Melbourne!
Explore the complete list and learn more about each speaker on the Workshop Website: vasculitis-melbourne2026.com/plenary-spea...
The success rate for NHMRC Ideas Grants announced yesterday was just over 8%. That means 11 of every 12 people who applied got rejected. This is a culture changing level of rejection and frankly a point of national shame. This is a crisis for research.
I will not rest until we see this resolved.
The program for the 22nd International Vasculitis Workshop has now launched!
Filled with amazing plenary speakers and sessions. Visit the website vasculitis-melbourne2026.com/program-full/ and start planning your Workshop!
No spiro if eGFR<45! How weird
Spent many a holiday there as a young adult. Check out Hahei of possible. A beautiful spot
A Fantastic band from my home country. All their albums are excellent.
Up next: It might seem a little fishy, but was a great catch 🎣 #NephJC
PISCES, the use of fish oil to decrease mortality in dialysis patients.
www.pubmed.ncbi.nlm....
I have no idea what time this is in Australia. I’ll have to try !
Mark your diaries! The ViCBiostat Summer School returns from 13-20 Feb 2026, in Melbourne and online.
Courses include causal inference, cluster randomised trials, meta-analysis and the estimand framework.
Further details TBA shortly - sign up to our mailing list at www.vicbiostat.org.au
#statistics
JAMA graph: Discordance in Creatinine- and Cystatin C-Based eGFR. Figure 2 shows association of estimated glomerular filtration rate difference with risks of long-term adverse outcomes. Hazard ratio vs. Difference between eGFRcys and eGFRcr, % for Death, CVD death, Heart failure, ASCVD, KFRT.
Among more than 800 000 CKD-PC participants, discordance between cystatin C and creatinine eGFR values was associated with increased risk of death, cardiovascular events, and kidney failure.
ja.ma/47A5Gdd
Final Chance!
Early bird registrations for the International Vasculitis Workshop 2026 close 14 November - and they won’t be extended again.
Register at vasculitis-melbourne2026.com/registration/
As the Australian PI I have to say I agree. PISCES took 10 years to do as best we could on minimal funding. The result is what it is - we will try to look further in to the data but given the low cost/ low risk what would be the point in doing another larger study? It would be hard to find funding
JAMA graph shows association of eGFR difference with risks of long-term adverse outcomes. Hazard ratio vs. difference between eGFRcys & eGFRcr (%). Lines for death, CVD death, heart failure, ASCVD, KFRT are plotted. Declining risk as difference approaches zero.
Among more than 800 000 CKD-PC participants, discordance between cystatin C and creatinine eGFR values was associated with increased risk of death, cardiovascular events, and kidney failure.
#KidneyWK @asnkidney.bsky.social
ja.ma/4oV4DtU
In PISCES, daily n–3 fatty acids cut serious cardiovascular events in dialysis patients by nearly half (HR 0.57). Fish oil clearly had bigger fish to fry than placebo: fewer MIs, strokes, cardiac deaths without extra adverse catches
@nejm.org #kidneywk sim publication
www.nejm.org/doi/full/10....
Shocking first high impact trial of the day. Fish oil reduces CV events in dialysis patients! #Pisces #kidneywk
Simultaneous pub in NEJM
www.nejm.org/doi/full/10....
Very proud to have lead the Australian arm of PISCES. Huge thanks for Charmaine Lok for the collaboration.
Recall only a few years ago that the late breaking trials session often has post hoc observation analyses or another negative HD or AKI trial. Indeed it is fantastic. More tomorrow…
Make the most of Melbourne while visiting for the 22nd International Vasculitis Workshop! Explore hidden laneway cafes, explore the coast or unwind in the Royal Botanic Gardens.
Check out the LOC Melbourne Guides: vasculitis-melbourne2026.com/loc-melbourn...
Yes Finerenone okay given the data already out. Plus it will likely get a HF indication by as well. For Atacicept even with the positive slope data one trial in 200 patients won’t cut it I suspect in Australia.